Actively Recruiting

Age: 14Years +
All Genders
ID03364803

Treatment Outcomes for Patients With Cushing's Syndrome: a Prospective Data Collection Study

Led by Memorial Sloan Kettering Cancer Center · Updated on 2025-10-23

300

Participants Needed

7

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are following participants with Cushing's syndrome to collect data during their routine care and to create a registry for studying long-term outcomes. This observational study focuses on patients aged 14 and older with active or treated overt Cushing's syndrome, mild adrenal Cushing's syndrome (MACS), or silent corticotroph tumors. The study is sponsored by Memorial Sloan Kettering Cancer Center and aims to gather information up to 10 years after various treatments. Participants undergo data collection before and over time after receiving surgical, medication, and/or radiation therapies. Various questionnaires are used to assess quality of life, general health, anxiety, depression, stress, impulsivity, food cravings, and related symptoms. These tools include the Cushing's QoL, Nottingham Health Profile, Hospital Anxiety and Depression Scale, Perceived Stress Scale, Barratt's Impulsivity Scale, Beck Depression Inventory, State-Trait Anxiety Inventory, Food Craving Questionnaires, Visual Analogue Scale, and the STRAP-R food variant. During the study, participants will complete these questionnaires and provide ongoing data related to their condition and treatments. Researchers monitor outcomes up to 10 years following treatment, focusing on changes in health, quality of life, and psychological symptoms. This long-term observation helps improve understanding of Cushing's syndrome outcomes under regular medical care.

CONDITIONS

Brief Title

Collecting Information About Treatment Results for Patients With Cushing's Syndrome

Who Can Participate

Age: 14Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 14 or older
  • Diagnosed with active or treated overt Cushing's syndrome from pituitary, ectopic, or adrenal tumors, mild adrenal Cushing's syndrome (MACS), or silent corticotroph tumors
  • Diagnosis made by the principal investigator following Endocrine Society guidelines, clinical presentation, and judgment
  • Diagnostic criteria include elevated urinary free cortisol, plasma ACTH levels, midnight salivary cortisol, dexamethasone suppression tests, pituitary MRI, or pathology confirming ACTH tumor
  • In absence of MRI, surgical, or lab reports, physician's assessment notes confirming diagnosis are acceptable
Not Eligible

You will not qualify if you...

  • Diagnosis of iatrogenic Cushing's syndrome

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - Up to 10 years after treatment

Participants with Cushing's Syndrome are observed before and over time after surgical, medication, and/or radiation therapy to collect information on treatment outcomes.

Visits occur periodically over up to 10 years after treatment

Trial Site Locations

Total: 7 locations

1

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

Basking Ridge, New Jersey, United States, 07920

Actively Recruiting

2

Memorial Sloan Kettering Monmouth (Limited Protocol Activities)

Middletown, New Jersey, United States, 07748

Actively Recruiting

3

Memorial Sloan Kettering Bergen (Limited Protocol Activities)

Montvale, New Jersey, United States, 07645

Actively Recruiting

4

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)

Commack, New York, United States, 11725

Actively Recruiting

5

Memorial Sloan Kettering Westchester (Limited Protocol Activities)

Harrison, New York, United States, 10604

Actively Recruiting

6

Memorial Sloan Kettering Cancer Center

New York, New York, United States, 10065

Actively Recruiting

7

Memorial Sloan Kettering Nassau (Limited Protocol Activities)

Uniondale, New York, United States, 11553

Actively Recruiting

Loading map...

Research Team

E

Eliza Geer, MD

M

Marc Cohen, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Single Center Randomized Controlled Study on the Promotion...

Nonfunctional Adrenal Cortex Adenoma

Actively Recruiting

1 location

A Phase 1b/2a Open-label Multiple-ascending Dose Study of CR...

Cushing Syndrome

Actively Recruiting

1 location

A Phase II Open-label Trial to Evaluate Safety, Tolerability...

Cushing's Disease

Actively Recruiting

26 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here